---
title: Pharcavir
image: "/uploads/04-pharcavir.jpg"
group: Hepatitis B
ingredient: Tenofovir alafenamide (administered as Tenofovir alafenamide fumarate
  28.05 mg)
excipients: Lactose monohydrate, Microcrystalline cellulose 112, croscarmello sodium,
  corn starch, magnesium stearate, opadry AMB II, yellow iron ocyd, ect. just enough
  for 1 tablet.
assign: Treatment of chronic hepatitis B in adults and adolescents (from12 years and
  above with a weight of 35 kg).
expiry_date: 36 months
pack: |-
  - Box of 03 blisters x 10 film-coated tablets, Alu - Alu blisters, with instruction sheet.
  - Box of 06 blisters x 10 film-coated tablets, Alu - Alu blisters, with instruction sheet.
preservation: Store in a cool and dry place at a temperature not exceeding 30Â°C.
origin: Viet Nam
amount_use: |-
  For adults and adolescents (from 12 years old and above with a weight of 35kg): Take 1 tablet / time x 1 time / day.
  Should be taken at the same time of day.
  For oral administration, the drug should be taken with food.
contraindications: Do not use Pharcavir for patients who are allergic to the active
  ingredient or any of its substances.
careful: |-
  - Patients with decompensated cirrhosis.
  - Exacerbation of liver disease.
  - CKD.
  - Renal toxicity.
  - Patients infected with hepatitis B and hepatitis C or D at the same time.
  - Patients infected with hepatitis B and HIV simultaneously.
  - Concomitant use with other products: products containing tenofovir alafenamide, tenofovir disoproxil fumarate or adefovir dipivoxil, antiepileptic drugs, products containing lactose, potent inhibitors of P-gp (e.g. itraconazole and ketoconazole).
order: 

---
